MedTrace Logo

EPIC European Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

NCT00309803 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-10-21

No results posted yet for this study

Summary

Multicenter, prospective, study designed to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention. The primary endpoint is the rate of all stoke and death within 30 days of the procedure.

Conditions

  • Carotid Artery Stenosis

Interventions

DEVICE

FiberNet Embolic Protection Device

Sponsors & Collaborators

  • Lumen Biomedical

    lead INDUSTRY

Principal Investigators

  • Joachim Schofer, Prof. med. · Andreas-Gruntzig-Haus

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00309803 on ClinicalTrials.gov